Description

NSE announces web-based bidding platform availability for takeover offer of Vilin Bio Med Limited by multiple acquirers from September 1-15, 2025.

Summary

NSE has enabled its web-based bidding platform for the takeover offer of Vilin Bio Med Limited by a consortium of 8 acquirers and 2 persons acting in concert. The tender offer will run from September 1-15, 2025 (excluding September 5) with a fixed offer price of Rs. 23.40 per share for up to 36,27,000 equity shares.

Key Points

  • Eight acquirers led by Mr. Allu Rama Krishna Reddy along with two PACs are making the takeover offer
  • Offer size: Up to 36,27,000 equity shares at Rs. 23.40 per share
  • Fixed price takeover offer with no modification or cancellation permitted
  • Face value: Rs. 10 per share, lot size: 4,000 shares
  • ISIN: INE0L4V01013
  • Merchant banker: AFCO Capital India Private Limited
  • Registrar: Bigshare Services Private Limited

Regulatory Changes

No new regulatory changes introduced. The offer follows existing Tender Offer Scheme as per NSE circular NSE/CMTR/52776 dated June 29, 2022.

Compliance Requirements

  • All Capital Market segment trading members eligible to participate
  • Members without existing access must use admin terminal to create branches and users
  • Custodial confirmation required during bidding hours and extended until 4:00 PM on issue closure day
  • Bidding categories include FII, MF, IC, FI, OTH, CO, IND, and NOH

Important Dates

  • Issue Period: September 1-15, 2025 (excluding September 5, 2025 due to Id-E-Milad)
  • Bidding Hours: 9:15 AM to 3:30 PM
  • Custodial Confirmation: 9:15 AM to 4:00 PM on closure day
  • Platform URL: https://eipo.nseindia.com

Impact Assessment

Moderate impact limited to Vilin Bio Med Limited shareholders who may participate in the tender offer. The established web-based bidding platform ensures orderly price discovery and transparent participation across investor categories. No broader market implications expected as this is a company-specific corporate action following standard procedures.

Impact Justification

Standard takeover offer procedure affecting specific company shareholders with established bidding mechanism